Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes.
Saved in:
| Title: | Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes. |
|---|---|
| Authors: | Grace RF; Division of Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorder Center, Boston, Massachusetts., Shimano KA; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, UCSF Benioff Children's Hospital, San Francisco, California., Bhat R; Center for Cancer & Blood Disorders, Ann and Robert H. Lurie Childrens Hospital of Chicago, Feinberg School of Medicine, Northwestern University, Chicago, Illinois., Neunert C; Division of Hematology, Oncology, and Stem Cell Transplant, Columbia University Medical School, New York, New York., Bussel JB; Department of Pediatrics, Weill Cornell Medicine, New York, New York., Klaassen RJ; Division of Hematology/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada., Lambert MP; Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Rothman JA; Division of Pediatric Hematology/Oncology, Duke University Medical Center, Durham, North Carolina., Breakey VR; Division of Pediatric Hematology/Oncology, McMaster University, Hamilton, Ontario, Canada., Hege K; Division of Pediatric Hematology/Oncology, Riley Hospital at IU Health, Indiana University School of Medicine, Indianapolis, Indiana., Bennett CM; Division of Hematology/Oncology, Aflac Cancer and Blood Disorders Center, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia., Rose MJ; Division of Hematology, Oncology, and Bone Marrow Transplant, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, Ohio., Haley KM; Division of Pediatric Hematology, Oregon Health & Science University, Portland, Oregon., Buchanan GR; Division of Hematology-Oncology, University of Texas Southwestern Medical Center, Dallas, Texas., Geddis A; Division of Pediatric Hematology/Oncology, University of Washington, Seattle Children's Hospital, Seattle, Washington., Lorenzana A; Division of Pediatric Hematology/Oncology, St. John Ascension Hospital, Detroit, Michigan., Jeng M; Department of Pediatrics, Stanford School of Medicine, Palo Alto, California., Pastore YD; Division of Hematology/Oncology, CHU Sainte-Justine, Montreal, Québec, Canada., Crary SE; Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas., Neier M; Division of Pediatric Hematology/Oncology, Goryeb Children's Hospital, Morristown, New Jersey., Neufeld EJ; Division of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee., Neu N; Division of Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorder Center, Boston, Massachusetts., Forbes PW; Clinical Research Center, Boston Children's Hospital, Boston, Massachusetts., Despotovic JM; Department of Pediatrics, Hematology/Oncology Section, Baylor College of Medicine, Houston, Texas. |
| Source: | American journal of hematology [Am J Hematol] 2019 Jul; Vol. 94 (7), pp. 741-750. Date of Electronic Publication: 2019 Apr 29. |
| Publication Type: | Comparative Study; Journal Article; Multicenter Study; Observational Study; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
